NASDAQ$BTTC

Black Titan Corp · Q4 2017 earnings

Q4 2017 earnings · Reported Apr 2, 2018 (8 years ago) · Investor relations

Apr 2Dec 31, 2017

Total Revenue

$58K

Previous: $35K+65.7%

EPS (adj)

-$612.00

Previous: -$540.00-13.3%

Capital Expenditures

$20K

Previous: $75K-73.3%

Free Cash Flow

-$3.88M

Previous: -$2.48M-56.4%

Net Income

-$3.66M

Previous: -$2.33M-57.3%

Operating Income

-$3.37M

Previous: -$3.25M-3.7%

Gross Profit

-$2.25M

Previous: -$2.05M-9.4%

Cash & Equivalents

$7.52M

Previous: $14M-46.3%

Total Assets

$8.91M

Previous: $18.7M-52.3%

Stock-Based Comp

$480K

Previous: $256K+87.5%

Titan Pharmaceuticals · Revenue · Quarterly

$58K

Q4 2017+65.7%vs Q4 2016

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation